Evolent Health Inc (Class A) (EVH) exhibits 21.3% gross margins and -26.3% return on invested capital within Consumer Discretionary (Other Consumer Services), balanced against a 24.0x enterprise multiple and 4.8% implied options volatility.
Sustained 21.3% gross profitability converts into -21.9% operating margin and -26.3% ROIC, outpacing sector cost of capital.
ROIC: -26.3% // GM: 21.3%YoY revenue trajectory of -26.6% paired with 8.08% free cash flow yield supports self-funded R&D and capital return.
REV YOY: -26.6% // FCF YLD: 8.08%Altman Z-Score of 0.20 and Piotroski F-Score of 4/9 indicate low near-term refinancing stress.
ALTMAN Z: 0.20 // F-SCORE: 4/9Trading at 24.0x trailing P/E (— Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 24.0x // EV/EBITDA: —Options market prices a ±5.2% implied move with a 0.85 put/call ratio around $4.25 max pain.
IMPL MOVE: ±5.2% // P/C: 0.85Elevated industry capital intensity and customer concentration in Other Consumer Services require continuous execution to defend -30.9% net margins.
NET MARGIN: -30.9% // D/E: 2.34x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for EVH & activate live FRED threshold breach alerts.